Friday, April 18, 2025 | 10:49 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

WHO must approve India's vaccines 'at the earliest': Modi at G20 meeting

Country can produce more than 5 billion doses for the world next year to contain the coronavirus, he says.

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Press Trust of India Rome
India is ready to produce over 5 billion Covid vaccine doses next year to help the world in the fight against the pandemic, Prime Minister Narendra Modi said at a G-20 Summit session in Rome on Saturday and asserted that it was necessary that the WHO approves Indian vaccines "at the earliest".

A technical advisory group of the UN health agency will meet on November 3 to conduct a final "risk-benefit assessment" for Emergency Use Listing of Covaxin. Bharat Biotech's Covaxin and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India.
 
The prime minister, in his

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in